Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

Pfizer Tries To Revitalize Obesity Portfolio With $5 Billion Matsera Deal

Logo,Pfizer,Inc.,Is,An,American,Multinational,Pharmacological,And,Biotechnology

Pfizer Inc. (NYSE:PFE) on Monday agreed to acquire Metsera, Inc. (NASDAQ:MTSR) to accelerate the next generation of medicines for obesity and cardiometabolic diseases.

The acquisition brings a portfolio of differentiated oral and injectable incretin, non-incretin, and combination therapy candidates.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.